BioBridgeXAll companies

IMMvention Therapeutix, Inc.

Biotechnology company · Durham, North Carolina, United States

IMMvention Therapeutix, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $277,218 in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $2 million sold in a notice filed in 2023.

www.immventionthera.comProfile compiled from public records. Is this your company? Request a correction or update

IMMvention Therapeutix at a glance

Typebiotechnology company
HeadquartersDurham, North Carolina, United States
Earliest incorporation on record2017
Employees (self-reported, 2018)4
SEC CIK1837999

What does IMMvention Therapeutix do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $277,218 in total (2018). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $2 million sold (2023).

Frequently asked questions about IMMvention Therapeutix

Where is IMMvention Therapeutix headquartered?

IMMvention Therapeutix, Inc. is headquartered in Durham, North Carolina, United States.

What does IMMvention Therapeutix do?

IMMvention Therapeutix, Inc. is a biotechnology company.

When was IMMvention Therapeutix founded?

The earliest incorporation on record for IMMvention Therapeutix, Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences